ArticleJournal of thoracic disease2024

Safety and feasibility of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced esophageal squamous cell carcinoma: a prospective single-group phase II clinical study.

Lei Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.